微信直播

Prof. Miguel A. Cuesta:荷兰的食管癌治疗经验分享

Published at: 2015年第1卷第S1期

周丽桃
关键词:

编者按:胸怀大治,共创未来!由上海市防癌抗癌事业发展基金会和AME出版社主办的“胸怀大治—2017 胸部肿瘤规范化治疗上海国际论坛”于2017年10月19日-21日在上海完满举行。受大会主席陈海泉教授邀请,来自荷兰Vrije University Medical Center (Vumc)的Miguel A. Cuesta教授跟大家分享了欧洲与中国食管癌在发生率,肿瘤类型,位置,治疗方式以及筛检计划等的问题,以及目前欧洲对于食管癌治疗的研究。在大家意犹未尽之际,小编邀请了Miguel A. Cuesta教授针对食管癌治疗热点问题以及他的从医经历进行采访(图1)。

人物聚焦:Prof. Miguel A. Cuesta

Prof. Cuesta is currently Emeritus Professor of Gastrointestinal Surgery especially dedicated to Minimally Invasive Surgery at the Vrije University Medical Centre (Vumc) in Amsterdam, the Netherlands and received his medical degree from the Universidad de Navarra School of Medicine, Pamplona, Spain. He completed his Surgical Residence at the Vumc at Amsterdam.

In 1988, Prof. Cuesta joined the faculty staff at the Vumc where he became Professor and chief of the Gastrointestinal and Minimally Invasive Surgery Unit in 2001. Since 2014 he works in the Reinier de Graaf Hospital in Delft, Netherlands, exclusively dedicated to Upper GI surgery.

Prof. Cuesta’s research focuses on the implementation of Digestive Oncological Diseases in Minimally Invasive Surgery, with special dedication to Upper Gastrointestinal Oncological Surgery.

He has been Principal Investigator or Co-PI on over 10 funded Control Randomized Trials in which a comparison is made between Open conventional and Minimally Invasive Approaches, but also investigating the role of neoadjuvant therapy in esophageal and gastric cancer.

He has published over 300 papers, has written over 10 book chapters and be editor in chief of four books about Minimally Invasive Approach of Digestive Cancer, Upper Gastrointestinal Cancer and Postoperative Major Complications. Currently he is editing a book about Minimally Invasive Upper Abdominal Surgery.

图1. Miguel A. Cuesta教授和编辑合影

微创食管切除术应用于食管癌已经有20多年的历史,Cuesta教授在比较早前就已经接触这项技术,而且他本人一直致力于“微创对比开放”这一热点问题的研究。2012年曾在Lancet杂志发表一个关于食管癌微创和开放对比的多中心随机研究,2017年在Annals of Surgery上发表了这项研究的三年随访(TIME研究)。此外,Cuesta教授同时也是重磅Cross研究的参与者。食管癌的最佳治疗方式,这是一个具有争议性的问题。在日本,医生倾向于使用化疗再做手术,而在中国,医生们更倾向于直接做手术。而被问到对于食管癌的手术治疗的最佳方式时,Cuesta教授笑着说:“这是一个特别难的问题。但他个人支持先放化疗,随后再进行手术。”

作为从传统手术过渡到微创手术的“有故事”的人,对于如何克服从传统手术改为微创手术的学习曲线,Cuesta教授有着自己的见解。 他指出首先在原有的医学知识基础上需要对微创手术各项术式的基础知识非常的了解,其次是一个优秀的导师。Cuesta教授在Vrije University Medical Center工作了将近30年,非常热衷于外科工作和患者之间的交流。

更多精彩内容分享,欢迎观看视频:

采访问题

1. We have known that you have hold a variety of managerial and executive appointments both locally and internationally, and you have published over 300 peer reviewed articles. How can you balance the academic research and daily work?    

2. Would you introduce the development of Uniportal VATS in Europe?

3. What clinical challenges are you facing with in upper gastrointestinal malignancies after bariatric surgery?

4. What role does lymphadenectomy play in Esophageal Cancer?

5. What’s the progress of Neoadjuvant Chemoradio-therapy Surgery for Esophageal Cancer?

6. When you look back to your career as a surgeon and director, what is the thing that has made you proudest or most memorable?

采写编辑:周丽桃,AME Publishing Company

视频剪辑:麦雪芳,AME Publishing Company

comments powered by Disqus

附件